Munich Startup
Sedivention GmbH

Sedivention GmbH

Founded2021
Business ModelB2B
IndustryLife Science
This content was machine translated.

About Sedivention GmbH

Severe obesity causes more than 400,000 deaths annually and society-wide costs exceeding 2 trillion dollars worldwide. Yet there is a lack of scalable, affordable, and easily accessible therapy. Sedivention’s idea is to develop a broadly applicable interventional therapy comparable to a gastroscopy. Hunger is one of the main drivers of overeating and obesity. Hunger is mediated to the brain via the vagus nerve. Sedivention is developing a cryoballoon that ablates the vagus nerve from the stomach. This outpatient intervention takes approximately 20 minutes, costs significantly less than gastric bypass surgery, and does so without the morbidity and complications. In short: Sedivention is developing the first effective and scalable therapy for obesity. No scars, no pain, no surgical complications, no access barriers, no implants at an affordable price.

More like this

Discover more articles, startups, and events from the ecosystem

Tech Alliance With the UK: Munich Startups Benefit
Deals

Tech Alliance With the UK: Munich Startups Benefit

13.10.26
4 Min.
Munich Fintech Scalable Capital Expands to Austria
Deals

Munich Fintech Scalable Capital Expands to Austria

13.10.26
4 Min.
Women in Tech: Eva Bodenmüller & Grace Forsyth from Dais
Interviews

Women in Tech: Eva Bodenmüller & Grace Forsyth from Dais

13.10.26
7 Min.